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Rheumatoid arthritis (RA) research has been largely dependent on collagen induced arthritis (CIA) rodent
models, however, they may not translate well to humans due to innate differences in the size, physiology
and lifespan. The present study aimed to establish a CIA porcine model with the physical, hematological,
histopathological and etiological properties closer to their human equivalent in an attempt to better
meet the needs of RA research.
Three month old minipigs were administered of bovine type II collagen (CII) emulsiﬁed with complete
Freund's adjuvants on Day 1 and incomplete Freund's adjuvants on Day 22, via an intradermal or intra-
articular route. The clinical, radiological and hematological assessments of immunized animals were
made periodically until Day 43, during which period the onset and progression of arthritis was recorded
and characterized. In addition, the histopathological and micro-tomographic assessments of the cartilage
degradation with regard to mononuclear cell inﬁltration, and joint deformity indicated a higher severity
in the intradermal injection group over the intra-articular group.
With conﬁrmation of the susceptibility to heterogeneous CII for arthritis induction in minipig, the
potential suitability of this test system as a large animal model for RA has been demonstrated.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Rheumatoid arthritis (RA) is a common autoimmune disease
that affects about 0.5e1% of the adult population in the world (1).
RA is characterized by synovial hyperplasia, inﬂammatory cell
inﬁltration, cartilage degradation, bone erosion, joint destruction
and an increase in the levels of pro-inﬂammatory cytokines. Un-
derstanding of the disease pathogenesis and etiology, however, is
as-yet insufﬁcient for the development of new therapeutic strate-
gies (2).
To explore novel therapeutic strategy, and in a bid to understand
the pathogenesis of RA, several animal models have been estab-
lished in the preceding decades; these include mouse, rat, guinea
pig, and non-human primate (NHP) models. Of particular note are
the rodent models, which have had induced arthritis via speciﬁc
antigens as well as chemical reagents. These include models based399 7483 (HP); fax: þ65 6863
rmacological Society.
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d/4.0/).on collagen induced arthritis (CIA), streptococcal cell wall arthritis,
adjuvant induced arthritis, proteoglycan-induced arthritis, and
serum transfer induced arthritis. In addition to the above, geneti-
cally modiﬁed TNF-a transgenic mice and K/BxN transgenic mice
were developed as animal models for spontaneous RA (3).
Particularly, the preclinical research of RA has been enormously
relied on CIA rodent models (4). Since it was ﬁrst described by
Trentham et al. in 1977, immunization to heterologous type II
collagen (CII) has been widely applied due to the high incidence of
arthritis with similar pathology of human RA (5,6); the histopath-
ological changes associated with T-cell speciﬁc cellular and hu-
moral immunity against CII were revealed in the CIA model, with
induced autoimmune arthritis characterized by an increase in CII
reactive immune cells, synovial hyperplasia, bone erosion, cartilage
degradation, mononuclear cell inﬁltration and a sensitivity to the
MHC class II haplotype (7). The utilization of CIA has, in this way,
contributed to an understanding of RA pathogenesis, and the
development of novel therapeutic agents (8e11).
Despite the high efﬁciency and proven achievement of inducing
RA in CIA rodent models, research applications have been limited
due to constraints imposed by small size and short lifespan of thenese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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differences in the anatomy, physiology and genetics between ro-
dents and humans. Therefore, large animal model has become of
main importance in the preclinical and pharmacological evalua-
tions, but a large animal CIA model has, to date, not been suc-
cessfully established (8,11).
Porcine disease models, owing to a greater similarity in the
anatomy and physiology with their human equivalents, have
proven to be more effective in aiding the understanding of human
disease pathogenesis as well as in the development of new thera-
peutic substances. In light of this, the present study focused on
establishing a large animal RA model by way of CIA minipigs. As-
sessments were made of the clinical, hematological, radiological
and histopathological features of minipigs post immunization to
heterologous CII. Collectively, CIA porcine model is expected to
have a greater translational potential than the current rodent
models, which enables researchers to study a wide range of long
term trials or the clinical treatments requiring human-equivalent
size models.
2. Methods
2.1. Ethics
All procedures, including induction of arthritis, animal care and
animal termination, were approved by the Institutional Animal
Care and Use Committee (IACUC).
2.2. Induction of arthritis
Arthritis was induced according to the previous DBA/1 CIA
mouse protocol with minor modiﬁcations (6,12). A total of 11 spe-
ciﬁc pathogen free (SPF) minipigs (PWG Genetics, Singapore), 3e4
month old males with approximately 7 kg body weight, was
employed in this study. They were divided into 3 experimental
groups; the intradermal injection group (ID group) had 5 animals
assigned, the intra-articular injection group (IA group) drew 3 an-
imals, and the ﬁnal 3 animals were placed in control group. All
animals were sedated with an intramuscular injection of ketamine
(10 mg/kg) and xylazine (2.5 mg/kg), and anesthesia was main-
tained by isoﬂurane inhalation. The ID group was administered
with a mixture of 1 mg/ml/kg bovine type II collagen (CII; Chon-
drex, WA, USA) emulsiﬁed with an equivalent volume of complete
Freund's adjuvant (CFA; Chondrex) intradermally on Day 1. To
maintain the stability of intradermal injections and to reduce the
risk of possible skin ulceration, each 0.1e0.2 ml of mixture was
distributed over 40 to 80 spots across the dorsal region. The second
immunization was performed on Day 22 using same procedure
except the use of incomplete Freund's adjuvant (IFA; Chondrex)
instead of CFA. The IA group received 1 mg/ml mixture of CII
emulsiﬁedwith equivalent volume of CFA or IFA on Day 1 or Day 22,
respectively, via direct injection into both the knee joint cavities.
Control group received injections of an equivalent volume of
phosphate buffered saline (PBS; Sigma, MO, USA) via both the ID
and IA routes.
2.3. Gross observation and clinical evaluation
The clinical evaluations and body temperatures were recorded
every three days from the second immunization day (Day 22) to
Day 43 by three separate personnel. The criteria of the clinical
evaluation at each limb were based on previously established
standards, and were summarized in Table 1 (6). Rectal tempera-
tures were measured using a digital centigrade thermometer. Hind
paw thickness was measured in triplicate by three differentevaluators with digital caliper ruler at the widest region of the
tarsal joint on Day 22 and Day 43. The difference of hind paw
thickness was calculated by subtracting Day 22 values from those
on Day 43.
2.4. Radiological and hematological assessment
The tarsal joints of all groups were scanned for the morpho-
logical changes on Days 22 and 43 using a C-arm X-ray (Zen-2090,
Genoray, Sungnam, Korea). Upon sacriﬁce on Day 43, the tarsal
joints were harvested and subsequently scanned by micro-
tomography (micro-CT; SMX-100CT, Shimadzu, Kyoto, Japan) to
examine structural changes on the tarsal joints in response to
arthritis development. Additionally, complete blood counts (CBC)
were analyzed using an ADVIA 2120 Hematology Analyzer
(Siemens, NJ, USA) on Days 1, 15, 29 and 43; special attention was
paid to the total number of WBCs, neutrophils, lymphocytes and
monocytes in a bid to monitor any inﬂammatory response.
2.5. Histopathological assessment
All groups were euthanized on Day 43 with a thiopental sodium
overdose. Themetatarsophalangeal joints were harvested and ﬁxed
in 10% formaldehyde (Sigma) for 3 days. Fixed samples were then
trimmed in 2 cm width  2 cm length  2 mm thickness, decal-
ciﬁed with Decalcifying Solution-Lite (Sigma) for 24 h, dehydrated
and embedded in parafﬁn. Slides of 4 mm sections were stained
with Masson's trichrome (Sigma) as well as hematoxylin and eosin
(H&E; Sigma) before being observed under a light microscope
(Nikon, Tokyo, Japan). The thickness of randomly selected 5 non-
calciﬁed cartilage regions was measured using the NIS elements
program (Nikon).
2.6. Statistical analysis
One-way ANOVAwas conducted in SPSS (IL, USA) with a Games-
Howell post-hoc test to discern signiﬁcant differences. Data were
presented as the mean ± standard error of the mean (SEM). The p
value less than 0.05 was considered as signiﬁcant difference.
3. Results
3.1. Gross observation
One minipig in the ID group perished shortly after the ﬁrst
immunization; it was speculated that the pig suffered accidental
intravenous injection of CII emulsiﬁed with CFA, but no further
examinationwas conducted. Another minipig from the same group
showed no clinical changes up to Day 43 and was therefore
considered an unsuccessful induction. Symptoms of swollen joint
such as the disappearance of plantar creases, thickened metatarsal
joints and increased distance of each digit were featured promi-
nently in the other 3 animals in the ID group, as well as all 3 animals
in the IA group. Cases representative of the aforementioned
symptoms may be observed in Fig. 1.
3.2. Clinical assessment
The clinical score of the ID group was signiﬁcantly higher
(p < 0.05) than the IA group from Day 28 onwards (Fig. 2a). The
maximum clinical score was reached into 1.95 ± 0.3 or 1.25 ± 0.19
points in the ID or IA group at terminal end point, respectively. Limb
swelling and erythema in both immunized groups were limited to
distal regions such as the metacarpal/metatarsal joints, digits and
palms, as opposed to more severe clinical signs including severe
Table 1
The criteria of the clinical evaluation.
Severity score Degree of inﬂammation
0 No evidence of erythema and swelling
1 Erythema and mild swelling to the carpals/tarsals or ankle/knee joint
2 Erythema and mild swelling extending from the carpals/tarsals to ankle/knee
3 Erythema and moderate swelling extending from the carpals/tarsals to ankle/knee
4 Erythema and severe swelling across the ankle/knee, arm/foot and digits
Fig. 1. Gross observation of hind legs on Day 22 and Day 43. Both immunized groups showed the swollen metatarsal joints and palms on Day 43 in comparisonwith those of Day 22.
Red arrows represented the morphological changes in regards to thickened joints, broadened inter-digital distance and disappearance of the plantar creases due to swelling. On the
other hand, there was no evidence of the incidence of arthritis in control group between Day 22 and Day 43.
Fig. 2. Clinical score, hind paw thickness and body temperature. (a) Each limb of animals was scored separately according to the standards for the clinical evaluation every three
days, and the average of points was calculated. (b) The difference of hind paw thickness was calculated by subtracting Day 22 values from those on Day 43. (c) Body temperature
from rectumwas measured every three days. X axis indicated days of study from Day 22 to Day 43, and Y axis presented values of each evaluation. *p < 0.05 vs. control, #p < 0.05 vs.
the IA group.
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(Fig. 1). In comparison with control group, the ID group presented
signiﬁcant (p < 0.05) increase of hind paw thickness on Day 43
(Fig. 2b) as well as a signiﬁcantly (p< 0.05) higher body temperature
fromDay 25 to Day 31 (Fig. 2c). However, no signiﬁcant difference in
the aforementionedwas observed between the IA and control group.
3.3. Radiological examination
The metatarsal/tarsal joints of both immunized groups were
examined with a C-arm X-ray, and ﬁndings included that indistinct
condyle surface and blurred margin of the joint were not identiﬁed
at joints in between immunized and control group on Day 22, but
progressively developed and appeared in immunized groups on
Day 43 (Fig. 3a). Harvested tarsal joints under images on micro-CT
showed clear arthritic manifestations including joint deformities
and dislocations when samples from both immunized groups were
compared with those of control group (Fig. 3b). The ID group, in
particular, presented more obvious morphological changes in the
joint than the IA group.
3.4. Hematological assessment
Both immunized groups recorded a signiﬁcantly (p < 0.05)
increasedWBC count 2 weeks after the ﬁrst immunization, and that
of the ID group showed the highest peak 1 week after the secondFig. 3. Radiological assessment by C-arm X-ray and the examination of the tarsal joints b
identiﬁed at joints between immunized and control groups on Day 22, but these ﬁndings wer
clinical ﬁndings on Day 43 were indicated as red arrows. (b) Harvested joints in both imm
deformities by micro-CT. Marks of asterisks were placed above the regions where deformitimmunization (Fig. 4a). Before animal termination on Day 43, the
number of WBC in both immunized groups was sustained as same
level as control group. The number of neutrophil, however,
remained elevated signiﬁcantly (p < 0.05) in both immunized
groups during whole experimental period than control group
(Fig. 4b). Furthermore, the ID group recorded a signiﬁcantly
(p < 0.05) higher level of lymphocytes 1 week after the second
immunization (Fig. 4c). While the total number of monocytes was
elevated in both immunized groups, it was not signiﬁcantly
important (Fig. 4d).3.5. Histopathological assessment
The histopathological assessments of the metatarsophalangeal
joint were conducted. Randomly selected 5 non-calciﬁed cartilage
regions showed signiﬁcantly (p< 0.05) degraded thickness in the ID
group in comparison with the IA and control group (Fig. 5aec and
g). However, destructed cartilages could be seen in both immunized
groups (Fig. 5h and j). Angiogenesis as well as increased inﬁltration
of mononuclear cells was observed extensively in the subchondral
region adjacent to the damaged articulation site in both immunized
groups, while most of mononuclear cells were only exhibited
within the bone marrow in control group (Fig. 5def). In addition,
the clusters of the inﬁltrated mononuclear cells in the subchondral
region were revealed in both immunized groups (Fig. 5i and k).y micro-CT. (a) Indistinct condyle surface and blurred margin of the joint were not
e progressively developed and appeared in merely immunized groups on Day 43. These
unized groups on Day 43 were compared with control group, and examined for their
ies and dislocation could be observed in both immunized groups.
Fig. 4. Complete blood count (CBC) for total number of WBC, neutrophil, lymphocyte and monocyte. CBC was performed every 2 weeks from Day 1. Mean baseline values of each
parameter were captured from all animals before the ﬁrst immunization and indicated as black dotted lines on each ﬁgure. Red arrow meant the second immunization day (Day 22).
X axis and Y axis indicated periods of study (0, 2, and 6 weeks) and cell population of each cell (103/mL), respectively. *p < 0.05 vs. control.
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The preceding decades have seen the establishment of both
induced and genetically modiﬁed spontaneous models of arthritis
(3,11,13). CIA, in particular, has been widely used due to its well
characterized mechanism of arthritis induction through the
administration of heterogeneous CII (13,14). This autoimmune
response against heterogeneous CII is led by the T helper cells,
which play a role in the adaptive immune system in combination
with pro-/anti-inﬂammatory cytokines and/or their receptors.
Since CII is rich protein in the articular cartilage, the cartilage begins
to be destroyed by the production of CII-speciﬁc antibodies as well
as cellular reactivity to CII (15,16). Due to similarities in the clinical
presentation, histopathology and immune response between CIA
animal and human RA, novel therapeutic strategies have frequently
been subjected to investigations utilizing CIA in mice, rats, guinea
pigs and NHP (8,14,17,18).
Despite the wealth of information on rodents as a base spe-
cies for CIA, RA studies involving rodents may not translate well
to humans due to innate differences in the size, physiology and
lifespan. Minipig-based models, with a higher level of similarity
to their human equivalents in terms of the physical, hemato-
logical, histopathological and etiological properties, were tested
for susceptibility to arthritis by the administration of hetero-
geneous CII. Following administration of bovine CII emulsiﬁed in
CFA and IFA, macroscopic observations of immunized minipigs
allowed for the identiﬁcation of swollen joints in both immu-
nized groups. These physical alterations were taken as the ﬁrst
clinical sign of arthritis induction, as with most CIA animal
models (6). Clinical signs of arthritis in regards to swollen jointswere observed from Day 27, with 3 out of 5 animals in the ID
group and 3 of 3 animals in the IA group (Figs. 1 and 2a). As a
point of reference, DBA/1 CIA mouse models have an incidence
rate of approximately 80e100% after 21e28 days of immuniza-
tion (6). Incidence rates, however, may vary depending on strain,
species, and origin of the CII administered. C57BL/6 mice, nor-
mally susceptible to bovine CII with a 50e80% incidence rate,
did not react to chicken or mouse CII. In addition, bovine CII
could only induce arthritis in about 70% of non-human primates
(2,18).
In the present study, it was found that while minipigs showed
the onset of arthritis, the arthritis did not progress aggressively at
the clinical observations. The ID group had a clinical score of
1.95 ± 0.3 points, only presenting with swelling in distal regions
such as the metacarpal/metatarsal joints, digits and palms (Fig. 2a).
Symptoms of a level of arthritis severity such as severe erythema,
ankylosis and extended swelling across the entire limb, able to be
scored as 3e4 points, were not obvious during the observation
period. DBA/1 CIA mouse model, generally presenting with a high
level of severity post immunization, has also shown varied inci-
dence results evaluated as 2e4 points (6,12,19e21). Similarly, CIA
models using Balb/c mice scored between 2 and 3 points post im-
munization with CII (22,23). Further, increased thickness in hind
paw is considered as one of the main physical changes associated
with the onset of arthritis in CIA animal (12,19). Upon observation,
the ID group presented the tarsal joint swelling as well as a sig-
niﬁcant (p < 0.05) elevation in thickness of the hind paw
(2.12 mm ± 0.42 mm) over control group (0.42 mm ± 0.3 mm). IA
group presented results midway in-between the ID and control
group (Fig. 2b).
Fig. 5. Histological assessment in the metatarsophalangeal joints for the measurement of the cartilage thickness, cartilage destruction and mononuclear cell inﬁltration. (aec) The
cartilage from control, the ID and IA groups was stained as blue by Masson's trichrome staining. (g) Randomly selected 5 non-calciﬁed cartilage regions in Masson's trichrome
staining were measured about those thicknesses. The cartilage thickness was presented as mean ± SEM. *p < 0.05 vs. control, #p < 0.05 vs. the IA group. (h, j) Cartilage destruction
could be observed in both immunized groups. (def) H&E staining was employed to determine the inﬁltration of mononuclear cells. Angiogenesis of small vessels was marked as
black arrows. (i, k) Blank arrows indicated the cluster of the inﬁltrated mononuclear cells in both immunized groups. Magniﬁcations are 40 (aef) and 200 (hek), respectively.
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with anomalous hematology such as anemia, neutropenia and
thrombocytopenia, these symptoms are generally not fully
observed in CIA animal models due to the nature of arthritis
induced by heterogeneous CII; the exogenous inducer mainly
causes acute arthritis with an early inﬂammatory response, instead
of the chronic arthritis prevalent in humans (8,24,25). CIA NHP
model may present with two different types of arthritis, namely of
the early and late-onset type. The latter type did not show neu-
tropenia even after 126 days of observation (26). In Fig. 4, both
immunized groups showed elevations of the total number of WBC
and neutrophil during days between the ﬁrst and second immu-
nization. Such inﬂammatory response post the ﬁrst immunization
could be supported by common observation during CIA protocol;
the intradermal immunization to mice with CII emulsiﬁed with CFA
gave rise to an inﬂammation at the injection site for 1e2 weeks
after the ﬁrst immunization (6). The ﬁrst signs of arthritis devel-
opment, away from injection site, are visible between Days 18 and
25 after the ﬁrst immunization in most of the CIA mice (2,6,21). In
the present study, the inﬂammatory reaction at the injection site
was maintained for 3 weeks, therefore, it was speculated that this
reaction resulted in the hematological changes of the total number
of WBC and neutrophil at 2 weeks after the ﬁrst immunization
(Fig. 4a and b). It was hard to observe any incidence of arthritis such
as swelling in the carpal/tarsal joints during days between the ﬁrst
and second immunization, but mild swelling at those joints started
to be seen from Day 25 (Fig. 2a). Furthermore, both immunized
groups showed signiﬁcantly (p < 0.05) elevated total WBC andneutrophil counts as well as increased tendency of lymphocyte and
monocyte counts at Day 29 in comparison with those levels of
control group. These changes have been taken as an indication of a
systemic response against exogenous CII post immunization.
WBC inﬁltration into the cartilage has been linked with cartilage
degradation and bone erosion in CIA animals (2,12). Both immu-
nized groups presented degraded and destructed cartilage
(Fig. 5aec, g, h and j), as well as an increase in the number of
inﬁltrated mononuclear cells into the subchondral region over
control group (Fig. 5def, i and k). Angiogenesis across the sub-
chondral region, a compensatory mechanism in response to hyp-
oxia during synovial expansion, has been regarded as an important
observation in human RA (27). In the present study, both immu-
nized groups displayed increased angiogenesis with red blood cell
ﬁlled vessels near the subchondral region, marking another point of
similarity between these groups and human RA.
The radiological features of RA have also beenwell documented,
especially with regards to synovitis, effusion, osteoporosis, nar-
rowing of the joint space and bone erosion (28). The radiological
examination using a C-arm X-ray revealed no obvious difference of
joints between immunized and control groups on Day 22, there-
fore, it was speculated that therewas no onset of arthritis till Day 22
in both immunized groups. But it was clearly identiﬁed that nar-
rowing of the joint space, and indistinct condyle surface and blur-
red margin of joints were observed in immunized groups on Day 43
in comparison with those on Day 22 and control group (Fig. 3b).
Additionally, micro-CT scans showed irregular grooves at the bone
margins, as well as a receded or nonexistent intra-articular joint
W.J. Lee et al. / Journal of Pharmacological Sciences 132 (2016) 41e47 47space and dislocations of the tarsal joints in both immunized
groups over control group (Fig. 3b). The aforementioned changes
were observed at a greater degree of severity in the ID group over
the IA group.
A variety of cytokines are related with the pathogenesis of CIA
rodent model. Ankle joint extracts in CIA rodent model present
drastic elevations of the inﬂammatory cytokines such as IL-1b, TNF-
a, and IL-6 (29). While TNF-a and IL-2 are associated with T helper
cell type 1 response to activate disease-boosting, IL-4 is related
with T helper cell type 2 to inhibit the arthritis (14). The immu-
nosuppressive properties of stem cells in CIA rodent model are
characterized by association with increased levels of IL-10 as the
anti-inﬂammatory cytokine as well as decreased levels of IL-1 as
the pro-inﬂammatory cytokine (30). Unfortunately, although the
present study and other studies that described large animal CIA
model clearly provided the evidence of the onset of arthritis, a
limitation was the lack of further study regarding changes of
cytokine proﬁle (18,26).
In the present study, the susceptibility of minipigs to arthritis
induction via administration of heterogeneous CII emulsiﬁed in CFA
and IFA was conﬁrmed with showing symptoms associated with
RA, such as joint swelling, increased joint thickness, the hemato-
logical alteration, degraded or destructed cartilage and inﬁltration
of monocyte to the subchondral region. Furthermore, the changes
in regards to narrowing of the joint space, indistinct condyle sur-
faces and the joint deformities were identiﬁed by the radiological
observation. The aforementioned symptoms also generally
appeared more severe in the ID group than the IA group. In light of
the ﬁndings put forth in this paper, it is hoped that CIA minipig
model may be recognized as a potentially suitable test system for
further research.
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